Alpha 2.0
Login Register
» Authors » Ivan Chivite

Ivan Chivite

Explore the profile of Ivan Chivite including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 66
Followers 0
Related Specialties
Infectious Diseases
Microbiology
General Medicine
Top 10 Co-Authors
Juan Ambrosioni
Montserrat Laguno
Lorena de la Mora
Maria Martinez-Rebollar
Josep Mallolas
Berta Torres
Ana Gonzalez-Cordon
Esteban Martinez
Alexy Inciarte
Elisa de Lazzari
Published In
J Antimicrob Chemother
Infect Dis Ther
Enferm Infecc Microbiol Clin (Engl Ed)
HIV Med
Int J STD AIDS
Affiliations
Soon will be listed here.
Recent Articles
11.
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study
de la Mora L, Pitart C, Morata L, Ugarte A, Martinez-Rebollar M, de Lazzari E, et al.
Infect Dis Ther . 2023 Jul; 12(8):2179-2189. PMID: 37491688
Introduction: There are no data on community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in the context of the chemsex phenomenon. This study aimed to characterize CA-MRSA-related infections in a cohort of...
12.
Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study
Martinez-Serra A, de Lazzari E, Berrocal L, Foncillas A, de la Mora L, Inciarte A, et al.
J Antimicrob Chemother . 2023 Jun; 78(8):1955-1962. PMID: 37311224
Background: The use of dolutegravir/lamivudine is based on solid clinical trials; however, real-world data remain limited. Objectives: To provide data on the clinical use and effectiveness of dolutegravir/lamivudine in persons...
13.
Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study
de Lazzari E, Berrocal L, Fernandez E, Laguno M, Chivite I, Torres B, et al.
Medicine (Baltimore) . 2023 Apr; 102(14):e33442. PMID: 37026943
Human immunodeficiency virus (HIV) infection is considered a chronic disease. Antiretroviral therapy has allowed persons with HIV (PLWHIV) to achieve the 90-90-90 objectives proposed by the World Health Organization for...
14.
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort
Palacio-Vieira J, Moreno-Fornes S, Diaz Y, Aceiton J, Bruguera A, Nomah D, et al.
HIV Med . 2023 Mar; 24(9):965-978. PMID: 36990962
Introduction: People living with HIV who are lost to follow-up have a greater risk of health deterioration, mortality, and community transmission. Objective: Our aim was to analyse both how rates...
15.
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020
Toyos S, Berrocal L, Gonzalez-Cordon A, Inciarte A, de la Mora L, Martinez-Rebollar M, et al.
Euro Surveill . 2023 Mar; 28(10). PMID: 36892474
BackgroundEpidemiological and immunovirological features of people living with HIV (PLWH) can vary by sex.AimTo investigate, particularly according to sex, characteristics of PLWH who consulted a tertiary hospital in Barcelona, Spain,...
16.
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience
Ugarte A, de la Mora L, Garcia D, Martinez-Rebollar M, de Lazzari E, Torres B, et al.
Infect Dis Ther . 2022 Dec; 12(2):425-442. PMID: 36520330
Introduction: Pre-exposure prophylaxis (PrEP) is effective for HIV prevention, but the PrEP care continuum also involves improving PrEP awareness, uptake, adherence, and retention in care. Users' awareness is often compromised...
17.
Do ART and Chemsex Drugs Get Along? Potential Drug-Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study
de la Mora L, Nebot M, Martinez-Rebollar M, de Lazzari E, Tuset M, Laguno M, et al.
Infect Dis Ther . 2022 Sep; 11(6):2111-2124. PMID: 36173594
Introduction: People living with HIV (PLWH) who engaged in chemsex are at risk of potential drug-drug interactions (pDDIs) with recreational drugs. This study aimed to characterize pDDIs between antiretroviral treatment...
18.
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement
Laguno M, Ugarte A, Martinez-Rebollar M, Sobrino Y, Font G, de Lazzari E, et al.
Enferm Infecc Microbiol Clin (Engl Ed) . 2022 Jul; 41(1):24-28. PMID: 35810144
Introduction: Pre-Exposure Prophylaxis (PrEP) is a biomedical intervention to prevent HIV infection in seronegative people at high risk of becoming infected. This strategy was endorsed in October 2019 by the...
19.
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain
de la Mora L, Ugarte A, Martinez-Rebollar M, de Lazzari E, Garcia-Hernandez D, Font G, et al.
AIDS Behav . 2022 Jun; 26(12):4055-4062. PMID: 35732910
Pre-exposure prophylaxis (PrEP) is a biomedical intervention that has demonstrated efficacy in HIV prevention in individuals at high-risk, among them chemsex users. Out of 190 PrEP users followed at Hospital...
20.
Short-term effectiveness and tolerability of carbon dioxide laser for anal high-grade squamous intraepithelial lesions in individuals living with HIV
Fuertes I, Chivite I, Cranston R, Sanchez E, Cordon E, Rodriguez-Carunchio L, et al.
Int J STD AIDS . 2022 May; 33(7):709-717. PMID: 35611790
Background: Ablative treatment of intra-anal high-grade squamous intraepithelial lesions (HSIL) reduces the risk of progression to anal squamous cell carcinoma. Our objective was to assess the short-term effectiveness and tolerability...